China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong · Delayed Price · Currency is HKD 5.16
-0.09 (-1.71%)
May 4, 2026, 4:08 PM HKT
HKG:3320 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Quarter | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 | H2 2021 | H1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 | Dec '21 Dec 31, 2021 | Jun '21 Jun 30, 2021 |
| 137,708 | 131,867 | 129,076 | 128,598 | 121,885 | 122,818 | 106,979 | 107,323 | 99,650 | 95,194 | |
Revenue Growth (YoY) | 6.69% | 2.54% | 5.90% | 4.71% | 13.93% | 14.44% | 7.36% | 12.74% | 6.58% | 16.84% |
Cost of Revenue | 114,709 | 110,357 | 109,320 | 107,664 | 103,309 | 103,058 | 90,902 | 90,393 | 85,055 | 80,672 |
Gross Profit | 22,998 | 21,510 | 19,755 | 20,933 | 18,577 | 19,761 | 16,077 | 16,930 | 14,595 | 14,522 |
Selling, General & Admin | 15,989 | 13,196 | 14,131 | 12,426 | 13,172 | 12,090 | 11,363 | 10,265 | 10,424 | 9,143 |
Other Operating Expenses | 1,637 | 1,038 | 1,136 | 1,012 | 1,353 | 691.21 | 1,140 | 712.47 | 875.16 | 557.94 |
Operating Expenses | 17,625 | 14,234 | 15,266 | 13,438 | 14,525 | 12,781 | 12,503 | 10,978 | 11,299 | 9,701 |
Operating Income | 5,373 | 7,275 | 4,489 | 7,496 | 4,052 | 6,980 | 3,574 | 5,952 | 3,296 | 4,821 |
Interest Expense | -1,009 | -1,004 | -1,087 | -1,175 | -936.55 | -1,426 | -1,235 | -1,151 | -1,019 | -1,214 |
Interest & Investment Income | 212.69 | 271.28 | 308.95 | 372.15 | 354.39 | 233.3 | 340.16 | 367.72 | 375.85 | 224.67 |
Earnings From Equity Investments | 148.73 | 113.24 | 169.24 | 198.77 | 205.09 | 212.01 | 167.89 | 158.71 | 139.2 | 118.67 |
Other Non Operating Income (Expenses) | 1,034 | 122.49 | 873.13 | 133.93 | 788.25 | 269.01 | 213.94 | -31.06 | 8.12 | 285.64 |
EBT Excluding Unusual Items | 5,760 | 6,778 | 4,754 | 7,026 | 4,463 | 6,268 | 3,061 | 5,297 | 2,799 | 4,236 |
Merger & Restructuring Charges | 2.74 | -2.74 | -1.18 | - | - | - | - | - | -7.02 | - |
Impairment of Goodwill | -185.6 | - | -92.23 | - | -82.81 | - | -85.14 | - | -100.82 | - |
Gain (Loss) on Sale of Investments | 10.96 | -331.22 | -743.49 | 23.08 | -268.56 | 47.88 | -195.08 | 27.92 | 51.34 | 51.36 |
Gain (Loss) on Sale of Assets | 38.19 | 4.92 | 71.82 | -1.69 | 61.38 | 2.48 | -24.26 | 346.57 | -0.23 | 8.23 |
Asset Writedown | -247.03 | -33.01 | -178.04 | -0.83 | -576.13 | -34.99 | -216.44 | -52.75 | -115.43 | - |
Other Unusual Items | 0.51 | - | 73.27 | - | - | - | - | - | 14.22 | - |
Pretax Income | 5,380 | 6,416 | 3,884 | 7,046 | 3,597 | 6,283 | 2,540 | 5,618 | 2,642 | 4,295 |
Income Tax Expense | 780.48 | 1,362 | 1,021 | 1,506 | 851.14 | 1,254 | 453.47 | 1,206 | 561.72 | 890.95 |
Earnings From Continuing Operations | 4,599 | 5,054 | 2,863 | 5,541 | 2,746 | 5,029 | 2,086 | 4,412 | 2,080 | 3,404 |
Minority Interest in Earnings | -2,631 | -2,976 | -2,117 | -2,936 | -1,573 | -2,347 | -1,262 | -1,830 | -995.63 | -1,377 |
Net Income | 1,968 | 2,077 | 746.05 | 2,605 | 1,173 | 2,682 | 824.43 | 2,582 | 1,084 | 2,027 |
Preferred Dividends & Other Adjustments | -0.6 | 3.95 | 19.59 | - | - | - | - | - | - | - |
Net Income to Common | 1,969 | 2,073 | 726.46 | 2,605 | 1,173 | 2,682 | 824.43 | 2,582 | 1,084 | 2,027 |
Net Income Growth | 163.81% | -20.25% | -36.38% | -2.87% | 42.23% | 3.84% | -23.96% | 27.39% | 78.84% | -13.70% |
Shares Outstanding (Basic) | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 |
Shares Outstanding (Diluted) | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 |
Shares Change (YoY) | - | - | - | - | - | - | - | - | - | -0.02% |
EPS (Basic) | 0.31 | 0.33 | 0.12 | 0.41 | 0.19 | 0.43 | 0.13 | 0.41 | 0.17 | 0.32 |
EPS (Diluted) | 0.31 | 0.33 | 0.12 | 0.41 | 0.18 | 0.43 | 0.13 | 0.41 | 0.17 | 0.32 |
EPS Growth | 171.01% | -20.40% | -36.98% | -2.87% | 39.83% | 4.17% | -23.96% | 26.99% | 78.84% | -13.68% |
Free Cash Flow | - | 246.36 | 16,964 | -2,073 | 17,925 | -4,899 | 12,590 | -3,907 | 10,339 | -1,881 |
Free Cash Flow Per Share | - | 0.04 | 2.70 | -0.33 | 2.85 | -0.78 | 2.00 | -0.62 | 1.65 | -0.30 |
Dividend Per Share | 0.122 | 0.072 | 0.052 | 0.083 | - | - | - | - | - | - |
Dividend Growth | 134.62% | -13.25% | - | - | - | - | - | - | - | - |
Operating Margin | 3.90% | 5.52% | 3.48% | 5.83% | 3.32% | 5.68% | 3.34% | 5.55% | 3.31% | 5.06% |
Profit Margin | 1.43% | 1.57% | 0.56% | 2.03% | 0.96% | 2.18% | 0.77% | 2.41% | 1.09% | 2.13% |
Free Cash Flow Margin | - | 0.19% | 13.14% | -1.61% | 14.71% | -3.99% | 11.77% | -3.64% | 10.38% | -1.98% |
EBITDA | 6,534 | 8,766 | 5,852 | 8,785 | 5,397 | 8,173 | 4,421 | 7,013 | 4,184 | 5,663 |
D&A For EBITDA | 1,161 | 1,491 | 1,363 | 1,289 | 1,345 | 1,193 | 847.73 | 1,061 | 888.12 | 841.96 |
EBIT | 5,373 | 7,275 | 4,489 | 7,496 | 4,052 | 6,980 | 3,574 | 5,952 | 3,296 | 4,821 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.